The global hemostats market in terms of revenue was estimated to be worth $2.8 billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 6.1% from 2023 to 2027.

The current edition of the report includes pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, trade analysis, technology analysis, regulatory landscape analysis, patent analysis, and Porter five forces analysis in the market overview chapter.

This edition of the report also covers the product and geographical footprint of key players in the competitive landscape chapter. Growth in this market is driven by the growing volume of surgical procedures performed, the rising focus on R&D, the increasing incidence of sports-related injuries and spinal ailments, and the rising focus on effective blood loss management in patients during surgeries. However, side effects and allergic reactions associated with hemostats are expected to hamper the adoption of these products. 

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9571619

Growth Drivers of Hemostats Market from Macro to Micro:

Macro Level:

• Aging Population: As the population ages, the prevalence of bleeding-related diseases increases, which is a major driver for the hemostat market.
• Growing Healthcare Expenditure: Governments are increasing their healthcare expenditure for the betterment of the general population, which is driving the demand for hemostats.

Micro Level:

• Technological Advancements: The advent of advanced technologies is driving the hemostat market. Technologies like ocular hemostats, laparoscopic hemostats, and endoscopic hemostats are becoming increasingly popular.
• Increasing Number of Surgeries: The growing number of surgeries is driving the demand for hemostats, as these devices are used to control bleeding during surgeries.

Orthopedic surgery application to dominate the hemostats market during the forecast period.

Based on the application, the hemostats is classified into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, reconstructive surgery, and other surgeries. The orthopedics segment is expected to hold highest share because of rising number of sports injuries such as ligament tears and factures.

US dominates the North American Hemostats Market.

Based on the North America region, the Hemostats Market is divided into US and Canada. US is expected to dominate the Hemostats Market. Growing demand for hemostats during surgeries, strong healthcare infrastructure, and growth in the geriatric population are the key factor driving market growth in the US.

The major players in the Hemostats market are C.R. Bard (US), Baxter (US), Teleflex Incorporated (US), Ethicon (Subsidiary of Johnson & Johnson) ( US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany),  Pfizer (US), etc.